Introduction: Nanoscale drug delivery systems are regarded as a promising strategy for improving the effectiveness and safety of chemotherapy. Yet, some synthetic nanocarriers may cause toxicity and immune responses, which can limit their biomedical application. A promising alternative is the development of biomimetic nanoparticles through their modification with cell membranes. This modification endows them with the biological functions of the donor cells. In this study, we have constructed hybrid nanoparticles based on extracellular vesicles and cell membranes, which are expected to combine high biocompatibility of vesicles, the functional properties of membranes and the ability to cross biological barriers.
Methods: Human embryonic kidney HEK293 cells were used as a source of extracellular vesicles and cell membranes. The effect of cell lysis buffer composition and components for efficient isolation of cell membranes (CM) was examined by testing four buffer systems based on (CM1) Tris-HCl and MgCl2, (CM2) 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and mannose, (CM3) NaHCO3, disodium EDTA, phenylmethylsulfonyl fluoride, and protease inhibitor cocktail, and (CM4) Tris-HCl, MgCl2, KCl and phenylmethylsulfonyl fluoride. The formation of hybrid nanoparticles was carried out by extrusion through polycarbonate membranes using an Avanti Mini-Extruder of mixed samples containing extracellular vesicles and CM. To optimize particle size distribution, we tested different numbers of extrusion cycles (5, 10, 15, 20, and 25). The isolated cell membranes and hybrid nanoparticles were characterized by dynamic light scattering to determine their mean hydrodynamic diameter and polydispersity index. Protein concentration was determined using BCA assay.
Results: Among tested buffer systems, the HEPES-containing buffer (CM2) provided the highest protein content 230 μg and the smallest mean hydrodynamic diameter 194±26 nm. It was hypothesized that the use of HEPES in the lysis buffer ensures more effective stabilization of membrane fragments and protects them from degradation and aggregation. For the remaining buffer systems, the following results were obtained: CM1 310±1 nm and 63 μg, CM3 1050±213 nm and 79 μg, CM4 281±9 nm and 33 μg. Regarding extrusion conditions, 15 extrusion cycles were optimal for obtaining hybrid particles with the monodisperse size distribution 110±22 nm and PDI 0.31±0.10.
Conclusions: Overall, method with HEPES-containing lysis buffer demonstrated promising performance for cell membranes isolation. The developed hybrid system represents a biocompatible platform for further in vitro studies as a drug delivery approach for cancer therapy.
This work was supported by the Russian Science Foundation research grant No. 25-75-00151, https://rscf.ru/project/25-75-00151/